Fred Hutchinson Cancer Center is an independent, nonprofit organization providing adult cancer treatment and groundbreaking research focused on cancer and infectious diseases. Based in Seattle, Fred Hutch is the only National Cancer Institute-designated cancer center in Washington.
With a track record of global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy and COVID-19 vaccines, Fred Hutch has earned a reputation as one of the world’s leading cancer, infectious disease and biomedical research centers. Fred Hutch operates eight clinical care sites that provide medical oncology, infusion, radiation, proton therapy and related services, and network affiliations with hospitals in five states. Together, our fully integrated research and clinical care teams seek to discover new cures to the world’s deadliest diseases and make life beyond cancer a reality.
At Fred Hutch we value collaboration, compassion, determination, excellence, innovation, integrity and respect. These values are grounded in and expressed through the principles of diversity, equity and inclusion. Our mission is directly tied to the humanity, dignity and inherent value of each employee, patient, community member and supporter. Our commitment to learning across our differences and similarities make us stronger. We seek employees who bring different and innovative ways of seeing the world and solving problems. Fred Hutch is in pursuit of becoming an anti-racist organization. We are committed to ensuring that all candidates hired share our commitment to diversity, anti-racism and inclusion.
The Ring Lab of Synthetic and Systems Immunopharmacology is located within the Translational Science and Therapeutics Division and is a member of the Immunotherapy Integrated Research Center (IIRC). Their primary focus is on developing unique and first-in-class therapeutic drugs for cancer immunotherapy using cutting-edge protein engineering with directed evolution. The lab has developed therapeutics that are currently in clinical trials, such as ST-067 (a "decoy-resistant" IL-18), MDNA-11 (CD122-biased IL-2), and ALX-148/evorpacept (an ultra-high affinity SΙRPα decoy). Moreover, the Ring Lab is actively working on developing platforms for discovering new targets in cancer immunotherapy, such as the REAP platform for discovering autoantibodies in patient samples, and high-throughput approaches in synthetic antibody discovery and characterization to identify new tumor antigens.
The Ring Lab is seeking a highly motivated individual to support their preclinical and translational research. The successful candidate will have the opportunity to work on cutting-edge techniques to study immune responses in preclinical models and human cancer patients and to develop new therapeutic agents to advance into clinical trials.
This is a long-term position that requires overseeing the day-to-day operations of the laboratory in conjunction with senior laboratory members. Responsibilities also include development of policies, procedures and methods; oversight of laboratory staff; management of projects and resources; and act as liaison and point of contact for laboratory. The successful applicant will also be responsible for contributing to various drug discovery and target identification projects. The candidate will also contribute to multiple projects related to drug discovery/development and target identification. The technician will be closely involved in research projects using both preclinical mouse models of cancer immunotherapy and handling/preparation of clinical samples for analysis.
In conjunction with the PI and senior laboratory members, key duties will include:
A Bachelor’s degree with at least eight years of professional lab experience in a related field with relevant techniques is required
A Master’s degree in a related field may substitute for some professional lab experience
Fred Hutchinson Cancer Center has a mandatory COVID-19 vaccine requirement, with exceptions only for approved medical or religious accommodations. As a condition of employment, newly hired employees must, prior to their first day of employment:
Provide proof of being fully vaccinated against COVID-19 ; OR
Initiate the accommodations process to request a religious or medical accommodation (medical accommodations require a healthcare provider’s certification).
A statement describing your commitment and contributions toward greater diversity, equity, inclusion, and antiracism in your career or that will be made through your work at Fred Hutch is requested of all finalists.
The annual base salary range for this position is from $70,817 to $106,225 and pay offered will be based on experience and qualifications.
Fred Hutchinson Cancer Center offers employees a comprehensive benefits package designed to enhance health, well-being, and financial security. Benefits include medical/vision, dental, flexible spending accounts, life, disability, retirement, family life support, employee assistance program, onsite health clinic, tuition reimbursement, paid vacation (12-22 days per year), paid sick leave (12-25 days per year), paid holidays (13 days per year), paid parental leave (up to 4 weeks), and partially paid sabbatical leave (up to 6 months).
Software Powered by iCIMS